From January 1, 2023 to March 31, 2023, the company has repurchased 125,250 shares, representing 0.14% for CNY 6.48 million. With this, the company has completed the repurchase of 2,643,924 shares, representing 2.88% for CNY 156.49 million under the buyback announced on September 6, 2022.
Beijing Hotgen Biotech Co., Ltd.
Equities
688068
CNE100003P82
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.55 CNY | 0.00% | -8.66% | -28.01% |
29/04 | Beijing Hotgen Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/04 | Beijing Hotgen Biotech to Buy Kaijing Gene Technology for 11 Million Yuan | MT |
1st Jan change | Capi. | |
---|---|---|
-28.01% | 37Cr | |
-4.82% | 18TCr | |
+3.73% | 11TCr | |
-2.64% | 6.86TCr | |
+5.50% | 5.16TCr | |
+7.61% | 4.42TCr | |
+9.45% | 4.36TCr | |
+25.59% | 3.25TCr | |
+20.94% | 2.6TCr | |
+0.21% | 2.56TCr |
- Stock Market
- Equities
- 688068 Stock
- News Beijing Hotgen Biotech Co., Ltd.
- Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on September 6, 2022.